WHO ICTRP trial
Evaluation of the therapeutic efficacy of injectable 5FU solution for basal cell…
IRCT20200205046380N2 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20200205046380N2 |
|---|---|
| Public title | Evaluation of the therapeutic efficacy of injectable 5FU solution for basal cell carcinoma in patients referred to Loghman Hakim and Shohada-e Tajrish hospitals between 2020 and 2021 |
| Scientific title | Evaluation of the therapeutic efficacy of injectable 5FU solution for basal cell carcinoma in patients referred to Loghman Hakim and Shohada-e Tajrish hospitals between 2020 and 2021 |
| Primary sponsor | Shahid Beheshti University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Iran (Islamic Republic of);Iran (Islamic Republic of) |
| Conditions | Basal cell carcinoma. Basal cell carcinoma of skin of lip;C44.01 |
| Interventions | Intervention group: 1-2 ml of the 50mg/ml 5FU solution (Kavosh Gostar Darou, Iran) will be injected in to the BCC lesion once a week until the resolution of the lesion or for a maximum duration of 6 weeks.. |
| Registration date | Sep 20, 2020 |
| Target size | 50 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: